Are there any noncovered indications for OPT with verteporfin to treat AMD?
Yes. The following AMD-related uses of OPT with verteporfin not already addressed in the NCD will continue to be noncovered. These indications include, but are not limited to: • Juxtafoveal or extrafoveal CNV lesions (lesions outside the fovea), • Inability to obtain a fluorescein angiogram, • Atrophic or “dry” AMD. Note: OPT with verteporfin for other ocular indications, such as pathologic myopia or presumed ocular histoplasmosis syndrome, continue to be eligible for local coverage determinations through individual contractor discretion.
